Charis Thompson

Alzheimer disease blood biomarkers: considerations for population-level use

Machine Learning and Digital Biomarkers Can Detect Early Stages of Neurodegenerative Diseases

Before it is too late: professional responsibilities in late-onset Alzheimer’s research and pre-symptomatic prediction